Liver Enzymes and Kidney Function: Why Monitoring Still Matters with Injectable Peptides
- vitalpathnp
- May 23
- 2 min read
Many patients wonder: “If peptides are injectable, don’t they bypass the liver and kidneys?” This is a very common question. While injections avoid first-pass metabolism in the digestive system, they do not completely bypass the liver or kidneys.
At Vital Path Medicine, we emphasize safety and transparent education for patients exploring peptide therapies like BPC-157, CJC-1295/Ipamorelin, Sermorelin, Tesamorelin, and others.
Why Injectable Peptides Still Affect Liver and Kidneys
Once injected, peptides enter the bloodstream and are eventually broken down (metabolized) by the liver. The kidneys then help eliminate the byproducts. This process means that even injectable peptides place a workload on these organs.
Key reasons monitoring remains important:
The liver processes and clears most peptides from the body.
The kidneys filter waste products created during metabolism.
Long-term or high-dose use can potentially stress these organs in sensitive individuals.
Important Labs to Monitor
Liver Function Tests
ALT and AST (main enzymes that can rise with stress)
ALP and Bilirubin
Kidney Function Tests
Creatinine
BUN
eGFR (estimated glomerular filtration rate)
We recommend baseline labs before starting peptides and periodic rechecks (typically every 3–6 months, or more frequently depending on the peptides and dosage).
Who Should Be Especially Vigilant?
Patients with any history of liver or kidney issues
Those using multiple peptides simultaneously
Older adults or individuals on other medications
Anyone planning longer cycles of therapy
Even healthy patients benefit greatly from monitoring to ensure continued safety.
Our Approach at Vital Path Medicine
We never prescribe peptides without proper lab evaluation. Your safety comes first. We use individualized protocols and close follow-up to minimize risks while supporting your wellness goals.
Medical Disclaimer: This blog is for educational and informational purposes only. Peptides such as BPC-157, Sermorelin, Tesamorelin, and CJC-1295/Ipamorelin are not FDA-approved for most wellness uses. The information provided does not constitute medical advice, diagnosis, or treatment. Regular lab monitoring and professional medical supervision are essential. Always consult with a qualified healthcare provider before starting or continuing peptide therapy.
Related Services & Resources
Sara Levin, NP-C is the owner and medical director of Vital Path Medicine, a virtual practice serving patients in AZ, CO, FL, IA, MA, NM, NV, OR, UT, DC. She has 15+ years of experience in ER, urgent care, integrative medicine, and medical weight loss. Learn more at Vital Path Medicine.
Comments